A patient presents with 12 hours following a myocardial infraction . Test of choice
**Question:** A patient presents with 12 hours following a myocardial infarction. Test of choice
A. Electrocardiogram (ECG)
B. Cardiac biomarkers (e.g., Troponin)
C. Coronary angiography
D. Echocardiography
**Correct Answer: B. Cardiac biomarkers (e.g., Troponin)**
**Core Concept:** Cardiac biomarkers are proteins released from damaged cardiac myocytes during myocardial infarction (heart attack). Troponin is a specific biomarker used to diagnose and monitor myocardial injury.
**Why the Correct Answer is Right:** Cardiac biomarkers, particularly high-sensitivity cardiac troponin (hs-cTn), are considered the gold standard for diagnosing myocardial infarction (MI). They are released into the bloodstream when cardiac myocytes are damaged, allowing for early detection of myocardial injury. Troponin is a specific biomarker that provides high sensitivity and specificity for acute MI.
**Why Each Wrong Option is Incorrect:**
A. Electrocardiogram (ECG): ECG changes are not specific for myocardial infarction and can be seen in various other conditions like arrhythmias and ischemia. ECG helps with the confirmation of ischemia; however, it is not sufficient as a single test to confirm MI diagnosis.
B. Coronary angiography: This test is invasive and not suitable for initial diagnosis of acute myocardial infarction. Cardiac biomarkers are a more practical and reliable option for early diagnosis of MI.
C. Echocardiography: Echocardiography assesses cardiac function and does not directly diagnose myocardial infarction. Cardiac biomarkers are essential for the confirmation of MI while echocardiography is valuable for assessing cardiac function post-MI.
**Clinical Pearl:** In patients presenting with suspected acute MI, a combination of clinical presentation, ECG changes, and elevated cardiac biomarkers is crucial for diagnosis. Timely initiation of reperfusion therapy and antiplatelet agents should be initiated based on clinical suspicion and biomarker elevation. Further evaluations, like echocardiography, can be performed later to assess cardiac function.
**Explanation of options:** Although ECG and echocardiography have their roles in cardiac evaluation, cardiac biomarkers are more reliable for the initial diagnosis of acute myocardial infarction. Coronary angiography is an invasive procedure that is not suitable for initial diagnosis.